Summary

The global remote patient monitoring market is projected to reach USD 56.94 billion by 2030 from 27.72 billion in 2024, at a CAGR of 12.7% from 2024 to 2030. Reason for growth in the remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. This affordability issue challenges patients to use remote patient monitoring technologies since they are experiencing difficulties coming up with money for basic healthcare services, not to mention coming up with money for new digital tools.
“Cloud based deployment is the fastest segment in the remote patient monitoring software by deployment market in 2023”
Cloud-based deployment is expected to be the fastest-growing segment in the remote patient monitoring market during 2023, mainly because this model has several advantages, such as easy integration of data from multiple cloud sources, unlimited access by users from remote locations, low maintenance costs, high security and privacy, easy access, no need to buy hardware up front, and excellent flexibility in the use of capacity and resources. A plethora of applications made accessible through the cloud-based model with core functionalities involving accounting, performance management, and also webmails and instant messages are all proving to be helpful in fueling this particular portion.
“North America dominated the remote patient monitoring market in 2023.”
The remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region's market. According to the Department of Health and Human Services' Office of Inspector General report, that Medicare enrolees receiving RPM increased more than 10-fold from 55,000 in 2019 to 570,000 in 2022, indicating a substantial increase in adoption.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation - C-level: 35%, Director-level: 40%, and Others: 25%
• By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), and VitalConnect (US) are some of the key players in the remote patient monitoring market.
• The study includes an in-depth competitive analysis of these key players in the remote patient monitoring market, with their company profiles, recent developments, and key market strategies.

Research Coverage
This research report categorizes the remote patient monitoring market by component (devices by function [cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, thermometers, other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)], by product type- [wearable devices, implantable devices, handheld & portable devices, others (stationary devices, and others)], software by deployment- [on-premise model and cloud-based model], by transmission type- [synchronous and asynchronous], and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and others (obstetrics & gynecology, immunology, infectious diseases, metabolic disorders, ophthalmology, gastroenterology, nephrology & urology, hematology, endocrinology, musculoskeletal disorders, and others)). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the remote patient monitoring market. Competitive analysis of upcoming startups in the remote patient monitoring market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (transforming patient care through digital innovation, telehealth driving growth in remote patient monitoring, rising prevalence of chronic diseases, growing geriatric population globally, need for cost-containment and improved patient care in healthcare industry, and wearables, health apps and connected devices enhancing remote patient monitoring solutions) restraints (high investments and lack of it expertise, behavioral barriers and healthcare affordability challenges in remote patient monitoring, and regulatory barriers in 2024 medicare policies impacting remote patient monitoring) opportunities (emergence of AI & ML, growing shift toward outpatient care environments, growing use in combating infectious diseases and enhanced patient care through early detection, hospital-at-home, and enhanced patient care through early detection and continuous monitoring) challenges (growing data security concerns data security issues, data accessibility issues, and integration of social determinants of health (sdoh) factors into rpm programs) influencing the growth of the remote patient monitoring market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the remote patient monitoring market
• Market Development: Comprehensive information about lucrative markets – the report analyses the remote patient monitoring market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the remote patient monitoring market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), and Siemens Healthineers AG); among others in the remote patient monitoring market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 MARKET SCOPE 34
1.3.1 MARKET SEGMENTATION 34
1.3.2 INCLUSIONS & EXCLUSIONS 35
1.3.3 YEARS CONSIDERED 36
1.3.4 CURRENCY CONSIDERED 36
1.4 LIMITATIONS 37
1.5 STAKEHOLDERS 37
1.6 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY DATA 42
2.1.2.1 Key data from primary sources 43
2.1.2.2 Breakdown of primary sources 44
2.2 MARKET SIZE ESTIMATION 45
2.2.1 SUPPLY-SIDE ANALYSIS 46
2.2.2 BOTTOM-UP APPROACH: END-USER ADOPTION 48
2.2.3 TOP-DOWN OF PARENT MARKET ASSESSMENT 49
2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 49
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
2.4 RESEARCH ASSUMPTIONS 54
2.4.1 MARKET SIZING ASSUMPTIONS 54
2.4.2 OVERALL STUDY ASSUMPTIONS 54
2.5 RISK ASSESSMENT 55
2.6 RESEARCH LIMITATIONS 55
2.6.1 METHODOLOGY-RELATED LIMITATIONS 55
2.6.2 SCOPE-RELATED LIMITATIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 60
4.1 REMOTE PATIENT MONITORING MARKET OVERVIEW 60
4.2 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER
AND REGION (2023) 61
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES 62
4.4 REMOTE PATIENT MONITORING MARKET: DEVELOPED MARKETS VS.
EMERGING MARKETS 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.1.1 DRIVERS 65
5.1.1.1 Transformation of patient care through digital innovation 65
5.1.1.2 Expansion of telehealth in remote patient monitoring 67
5.1.1.3 Rising prevalence of chronic diseases 67
5.1.1.4 Increasing geriatric population and rising uptake of RPM services 68
5.1.1.5 Growing need for cost-containment across healthcare facilities 69
5.1.1.6 Technological innovation in wearables, mhealth apps, and connected devices 70
5.1.2 RESTRAINTS 71
5.1.2.1 High investments and lack of IT expertise 71
5.1.2.2 Behavioral barriers and healthcare affordability challenges in remote patient monitoring 71
5.1.2.3 Challenges associated with 2024 CMS regulations 71
5.1.3 OPPORTUNITIES 72
5.1.3.1 Emergence of AI & ML 72
5.1.3.2 Gradual shift toward outpatient care environments 73
5.1.3.3 Increasing utilization for infectious disease diagnostics 74
5.1.3.4 Rising initiatives for hospital-at-home programs 74
5.1.4 CHALLENGES 75
5.1.4.1 Concerns associated with data security 75
5.1.4.2 Data accessibility issues 77
5.1.4.3 incorporation of SDOH factors into RPM programs 78
5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
5.2.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET 78
5.3 INDUSTRY TRENDS 79
5.3.1 GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE 79
5.4 ECOSYSTEM ANALYSIS 79
5.5 VALUE CHAIN ANALYSIS 81
5.6 TECHNOLOGY ANALYSIS 82
5.6.1 KEY TECHNOLOGIES 82
5.6.1.1 Miniature wearable devices 82
5.6.1.2 Artificial intelligence & machine learning 83
5.6.1.3 Cloud computing 83
5.6.1.4 Patient engagement tools 83
5.6.1.5 EHR integration 83
5.6.1.6 Voice assistant integration 84
5.6.2 COMPLEMENTARY TECHNOLOGIES 84
5.6.2.1 5G connectivity 84
5.6.2.2 mHealth apps 84
5.6.2.3 Digital therapeutics 84
5.6.2.4 Telehealth platforms 85
5.6.3 ADJACENT TECHNOLOGIES 85
5.6.3.1 POC diagnostics 85
5.6.3.2 Smart home health devices 85
5.7 TARIFF & REGULATORY ANALYSIS 86
5.7.1 TARIFF DATA (HS CODE 9018) 86
5.7.2 TARIFF DATA (HS CODE 9021) 87
5.7.3 TARIFF DATA (HS CODE 9022) 88
5.7.4 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 89
5.7.5 REGULATORY ANALYSIS 93
5.8 TRADE ANALYSIS 97
5.8.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES
(HSN CODE: 90189099) 97
5.8.2 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES
(HSN CODE: 9021) 98
5.8.3 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES
(HSN CODE: 9022) 99
5.9 PRICING ANALYSIS 100
5.9.1 INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES,
BY KEY PLAYER (2023) 101
5.9.2 INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES (2023) 102
5.10 PORTER’S FIVE FORCES ANALYSIS 102
5.10.1 THREAT OF NEW ENTRANTS 104
5.10.2 THREAT OF SUBSTITUTES 104
5.10.3 BARGAINING POWER OF MANUFACTURERS 104
5.10.4 BARGAINING POWER OF BUYERS 104
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 105
5.11 PATENT ANALYSIS 105
5.11.1 PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING 105
5.11.2 JURISDICTION AND TOP APPLICANT COUNTRIES FOR
REMOTE PATIENT MONITORING 106
5.11.3 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET 108
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 109
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 109
5.12.2 BUYING CRITERIA 110
5.13 END-USER ANALYSIS 110
5.13.1 UNMET NEEDS 110
5.13.2 END-USER EXPECTATIONS 111
 
5.14 KEY CONFERENCES AND EVENTS, 2025−2026 112
5.14.1 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025−2026 112
5.15 CASE STUDY ANALYSIS 113
5.15.1 REMOTE PATIENT MONITORING PORTAL AUTOMATION 113
5.15.1.1 Case 1: Cost savings and performance boost through automation 113
5.15.2 PATIENT MONITORING PORTAL AUTOMATION 114
5.15.2.1 Case 2: RPM drives engagement and generates substantial returns 114
5.16 INVESTMENT AND FUNDING SCENARIO 115
5.17 REMOTE PATIENT MONITORING BUSINESS MODEL 115
5.17.1 SUBSCRIPTION-BASED MODELS 115
5.17.2 PLATFORM AS A SERVICE (PAAS) 115
5.17.3 FREEMIUM MODELS WITH PREMIUM FEATURES 115
5.17.4 COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS 116
5.18 IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET 116
5.18.1 KEY USE CASES 117
5.18.2 CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION 118
5.18.2.1 Case study 1: Enhancing remote patient monitoring for cancer treatment with NLP and HIPAA-compliant annotation 118
5.18.2.2 Case study 2: Leveraging AI for proactive infection prevention in hospitals 119
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 120
5.18.3.1 Telehealth & telemedicine 120
5.18.3.2 Wearable devices 120
5.18.3.3 Digital healthcare 121
5.18.3.4 Home healthcare 121
5.18.4 USER READINESS & IMPACT ASSESSMENT 121
5.18.4.1 User readiness 121
5.18.4.1.1 User A: Hospitals 121
5.18.4.1.2 User B: Ambulatory surgery centers 121
5.18.4.2 Impact assessment 122
5.18.4.2.1 User A: Hospitals 122
5.18.4.2.1.1 Implementation 122
5.18.4.2.1.2 Impact 122
5.18.4.2.2 User B: Ambulatory surgery centers 122
5.18.4.2.2.1 Implementation 122
5.18.4.2.2.2 Impact 123
5.19 REIMBURSEMENT SCENARIO 123
6 REMOTE PATIENT MONITORING MARKET, BY COMPONENT 126
6.1 INTRODUCTION 127
6.2 DEVICES 127
6.2.1 BY FUNCTION 128
6.2.1.1 Cardiac monitoring devices 129
6.2.1.1.1 Increasing uptake of ECG monitors and rising cases of hypertension to fuel market 129
6.2.1.2 Neurological monitoring devices 130
6.2.1.2.1 Growing demand for clinical-grade wearable devices for routine monitoring to drive market 130
6.2.1.3 Respiratory monitoring devices 131
6.2.1.3.1 Rising demand for peak flow meters and sleep apnea monitors to fuel market 131
6.2.1.4 Blood glucose monitoring devices 132
6.2.1.4.1 Increasing prevalence of diabetes to support market growth 132
6.2.1.5 Fetal & neonatal monitoring devices 133
6.2.1.5.1 Growing focus on vital health monitoring in preterm births to drive market 133
6.2.1.6 Weight monitoring devices 134
6.2.1.6.1 High incidence of obesity and growing advancements in smart weighing scales to fuel market 134
6.2.1.7 Multiparameter monitoring devices 135
6.2.1.7.1 Measurement of spO2, blood sugar, and respiratory activity to fuel uptake 135
6.2.1.8 Pulse oximeter devices 136
6.2.1.8.1 Rising demand in preoperative & home care settings to support market growth 136
6.2.1.9 Thermometers 137
6.2.1.9.1 Growing focus on home healthcare to fuel market 137
6.2.1.10 Other monitoring devices 138
6.2.2 BY TYPE 139
6.2.2.1 Wearable devices 140
6.2.2.1.1 Ability to provide real-time insights to drive market 140
6.2.2.2 Implantable devices 141
6.2.2.2.1 Advancements in wireless communication technologies to boost demand 141
6.2.2.3 Handheld & portable devices 142
6.2.2.3.1 Growing focus on device miniaturization to fuel market 142
6.2.2.4 Other devices 143
6.3 SOFTWARE 143
6.3.1 SOFTWARE, BY DEPLOYMENT MODEL 144
6.3.1.1 On-premise models 145
6.3.1.1.1 Enhanced control, data security, and customization benefits to fuel market 145
6.3.1.2 Cloud-based models 145
6.3.1.2.1 Real-time data sharing and high-security features to boost demand 145
6.3.2 SOFTWARE, BY TRANSMISSION TYPE 146
6.3.2.1 Synchronous transmission 147
6.3.2.1.1 Growing availability of real-time data analytics to boost demand 147
6.3.2.2 Asynchronous transmission 148
6.3.2.2.1 Increasing need for low-resource flexible solutions to support market growth 148
6.4 SERVICES 148
6.4.1 EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH 148
7 REMOTE PATIENT MONITORING MARKET, BY INDICATION 150
7.1 INTRODUCTION 151
7.2 ONCOLOGY 151
7.2.1 GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET 151
7.3 CARDIOLOGY 153
7.3.1 HIGH INCIDENCE OF CVD TO PROPEL MARKET 153
7.4 NEUROLOGY 154
7.4.1 INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS
TO FUEL MARKET 154
7.5 DIABETES 155
7.5.1 GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND 155
7.6 SLEEP DISORDERS 156
7.6.1 INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH 156
7.7 RESPIRATORY DISEASES 157
7.7.1 RISING CASES OF COPD AND ASTHMA TO FUEL MARKET 157
7.8 WELLNESS IMPROVEMENT 158
7.8.1 UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH
APPS TO SUPPORT MARKET GROWTH 158
7.9 MENTAL HEALTH 159
7.9.1 GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS
FOR COGNITIVE THERAPY TO PROPEL MARKET 159
7.10 OTHER INDICATIONS 160
8 REMOTE PATIENT MONITORING MARKET, BY END USER 162
8.1 INTRODUCTION 163
8.2 HEALTHCARE PROVIDERS 163
8.2.1 HOSPITALS 165
8.2.1.1 Ability to purchase technologically advanced telehealth devices to fuel market 165
8.2.2 ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS 166
8.2.2.1 Increasing demand for cost-effective perioperative devices
to fuel market 166
8.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 166
8.2.3.1 Expanding geriatric population and growing focus on chronic disease management to fuel market 166
8.2.4 HOME HEALTHCARE 167
8.2.4.1 Growing preference for remote care to drive market 167
8.2.5 OTHER HEALTHCARE PROVIDERS 168
8.3 HEALTHCARE PAYERS 169
8.3.1 LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET 169
8.4 PATIENTS 170
8.4.1 INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES
TO BOOST DEMAND 170
8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 171
8.5.1 RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES
TO SUPPORT MARKET GROWTH 171
8.6 MEDTECH COMPANIES 172
8.6.1 INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR
DIAGNOSTIC ACCURACY TO FUEL MARKET 172
8.7 OTHER END USERS 173
9 REMOTE PATIENT MONITORING MARKET, BY REGION 174
9.1 INTRODUCTION 175
9.2 NORTH AMERICA 175
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 177
9.2.2 US 181
9.2.2.1 Supportive regulatory frameworks for AI implementation in wearable devices to boost demand 181
9.2.3 CANADA 186
9.2.3.1 Growing need to curtail healthcare costs to drive market 186
9.3 EUROPE 190
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 190
9.3.2 GERMANY 194
9.3.2.1 Favorable reimbursements for technological innovation to propel market 194
9.3.3 UK 198
9.3.3.1 Government support for AI implementation to boost demand 198
9.3.4 FRANCE 202
9.3.4.1 Implementation of ETAPES program to fuel market 202
9.3.5 ITALY 206
9.3.5.1 Growing focus on digital transformation for value-centric patient care to drive market 206
9.3.6 SPAIN 210
9.3.6.1 Rising funding investments for digital health plans to boost market 210
9.3.7 REST OF EUROPE 214
9.4 ASIA PACIFIC 218
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 218
9.4.2 CHINA 224
9.4.2.1 Shortage of physicians and growing focus on RPM solutions to support market growth 224
9.4.3 JAPAN 228
9.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market 228
9.4.4 INDIA 232
9.4.4.1 Expanding target patient population to drive market 232
9.4.5 REST OF ASIA PACIFIC 235
9.5 LATIN AMERICA 239
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 240
9.5.2 BRAZIL 244
9.5.2.1 Growing focus on telehealth consultations to drive market 244
9.5.3 MEXICO 248
9.5.3.1 Improvements in healthcare infrastructure to boost demand 248
9.5.4 REST OF LATIN AMERICA 252
9.6 MIDDLE EAST & AFRICA 256
9.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 256
9.7.1 GCC COUNTRIES 261
9.7.1.1 Government initiatives for investments in RPM solutions
to support market growth 261
9.7.2 REST OF MIDDLE EAST & AFRICA 264
10 COMPETITIVE LANDSCAPE 269
10.1 OVERVIEW 269
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 269
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET 269
10.3 REVENUE ANALYSIS, 2019–2023 274
10.4 MARKET SHARE ANALYSIS, 2023 275
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 278
10.5.1 STARS 279
10.5.2 EMERGING LEADERS 279
10.5.3 PERVASIVE PLAYERS 279
10.5.4 PARTICIPANTS 279
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 281
10.5.5.1 Company footprint 281
10.5.5.2 Region footprint 282
10.5.5.3 Component footprint 283
10.5.5.4 Indication footprint 284
10.5.5.5 End-user footprint 285
 
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 286
10.6.1 PROGRESSIVE COMPANIES 286
10.6.2 RESPONSIVE COMPANIES 286
10.6.3 DYNAMIC COMPANIES 286
10.6.4 STARTING BLOCKS 286
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 288
10.6.5.1 Detailed list of key startups/SMEs 288
10.6.5.2 Competitive benchmarking of startups/SMEs 288
10.7 COMPANY VALUATION & FINANCIAL METRICS 289
10.7.1 FINANCIAL METRICS 289
10.7.2 COMPANY VALUATION 289
10.8 BRAND/SOFTWARE COMPARISON 290
10.9 COMPETITIVE SCENARIO 291
10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 291
10.9.2 DEALS 293
10.9.3 EXPANSIONS 296
10.9.4 OTHER DEVELOPMENTS 296
11 COMPANY PROFILES 297
11.1 KEY PLAYERS 297
11.1.1 KONINKLIJKE PHILIPS N.V. 297
11.1.1.1 Business overview 297
11.1.1.2 Products/Services offered 298
11.1.1.3 Recent developments 302
11.1.1.3.1 Product/Service launches & approvals 302
11.1.1.3.2 Deals 303
11.1.1.4 MnM view 304
11.1.1.4.1 Key strengths 304
11.1.1.4.2 Strategic choices 304
11.1.1.4.3 Weaknesses & competitive threats 304
11.1.2 OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION) 305
11.1.2.1 Business overview 305
11.1.2.2 Products/Services offered 306
11.1.2.3 Recent developments 308
11.1.2.3.1 Product/Service launches 308
11.1.2.3.2 Deals 309
11.1.2.3.3 Other developments 309
11.1.2.4 MnM view 310
11.1.2.4.1 Key strengths 310
11.1.2.4.2 Strategic choices 310
11.1.2.4.3 Weaknesses & competitive threats 310
 
11.1.3 MEDTRONIC 311
11.1.3.1 Business overview 311
11.1.3.2 Products/Services offered 312
11.1.3.3 Recent developments 314
11.1.3.3.1 Product/Service approvals 314
11.1.3.3.2 Deals 315
11.1.3.4 MnM view 316
11.1.3.4.1 Key strengths 316
11.1.3.4.2 Strategic choices 316
11.1.3.4.3 Weaknesses & competitive threats 316
11.1.4 GE HEALTHCARE 317
11.1.4.1 Business overview 317
11.1.4.2 Products/Services offered 318
11.1.4.3 Recent developments 320
11.1.4.3.1 Product/Service launches & approvals 320
11.1.4.3.2 Deals 321
11.1.4.4 MnM view 322
11.1.4.4.1 Key strengths 322
11.1.4.4.2 Strategic choices 322
11.1.4.4.3 Weaknesses & competitive threats 322
11.1.5 ABBOTT 323
11.1.5.1 Business overview 323
11.1.5.2 Products/Services offered 324
11.1.5.3 Recent developments 325
11.1.5.3.1 Product/Service launches 325
11.1.5.3.2 Deals 326
11.1.5.3.3 Expansions 327
11.1.5.4 MnM view 327
11.1.5.4.1 Key strengths 327
11.1.5.4.2 Strategic choices 327
11.1.5.4.3 Weaknesses & competitive threats 327
11.1.6 ORACLE 328
11.1.6.1 Business overview 328
11.1.6.2 Products/Services offered 329
11.1.6.3 Recent developments 330
11.1.6.3.1 Deals 330
11.1.7 BOSTON SCIENTIFIC CORPORATION 331
11.1.7.1 Business overview 331
11.1.7.2 Products/Services offered 332
11.1.7.3 Recent developments 333
11.1.7.3.1 Product/Service launches & enhancements 333
11.1.7.3.2 Deals 334
11.1.7.3.3 Expansions 334
11.1.8 NIHON KOHDEN CORPORATION 335
11.1.8.1 Business overview 335
11.1.8.2 Products/Services offered 337
11.1.8.3 Recent developments 338
11.1.8.3.1 Product/Service launches 338
11.1.8.3.2 Deals 338
11.1.8.3.3 Expansions 339
11.1.9 SIEMENS HEALTHINEERS AG 340
11.1.9.1 Business overview 340
11.1.9.2 Products/Services offered 341
11.1.9.3 Recent developments 342
11.1.9.3.1 Product/Service launches & approvals 342
11.1.9.3.2 Deals 343
11.1.10 BAXTER 344
11.1.10.1 Business overview 344
11.1.10.2 Products/Services offered 346
11.1.10.3 Recent developments 346
11.1.10.3.1 Product/Service launches & approvals 346
11.1.10.3.2 Deals 347
11.1.11 BIOBEAT 348
11.1.11.1 Business overview 348
11.1.11.2 Products/Services offered 348
11.1.11.3 Recent developments 349
11.1.11.3.1 Product/Service launches & approvals 349
11.1.11.3.2 Deals 350
11.1.12 BIOTRONIK 352
11.1.12.1 Business overview 352
11.1.12.2 Products/Services offered 352
11.1.12.3 Recent developments 353
11.1.12.3.1 Product/Service launches & approvals 353
11.1.12.3.2 Deals 354
11.1.13 VITALCONNECT 355
11.1.13.1 Business overview 355
11.1.13.2 Products/Services offered 355
11.1.13.3 Recent developments 356
11.1.13.3.1 Product/Service launches 356
11.1.13.3.2 Deals 356
11.1.13.3.3 Other developments 357
 
11.1.14 VIVALNK, INC. 358
11.1.14.1 Business overview 358
11.1.14.2 Products/Services offered 358
11.1.14.3 Recent developments 359
11.1.14.3.1 Product/Service launches & enhancements 359
11.1.14.3.2 Deals 360
11.1.15 CLEARARCH, INC. 361
11.1.15.1 Business overview 361
11.1.15.2 Products/Services offered 361
11.1.15.3 Recent developments 362
11.1.15.3.1 Product/Service launches 362
11.1.15.3.2 Deals 363
11.1.16 OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM) 364
11.1.16.1 Business overview 364
11.1.16.2 Products/Services offered 365
11.1.17 BLUE SPARK TECHNOLOGIES, INC. 366
11.1.17.1 Business overview 366
11.1.17.2 Products/Services offered 366
11.1.17.3 Recent developments 367
11.1.17.3.1 Product/Service launches 367
11.1.17.3.2 Deals 367
11.1.17.3.3 Other developments 368
11.1.18 LIGHTBEAM 369
11.1.18.1 Business overview 369
11.1.18.2 Products/Services offered 369
11.1.18.3 Recent developments 370
11.1.18.3.1 Deals 370
11.1.19 CLOUD DIAGNOSTICS CANADA ULC 371
11.1.19.1 Business overview 371
11.1.19.2 Products/Services offered 371
11.1.19.3 Recent developments 372
11.1.19.3.1 Product/Service launches 372
11.1.19.3.2 Deals 372
11.1.20 TELADOC HEALTH, INC. 374
11.1.20.1 Business overview 374
11.1.20.2 Products/Services offered 375
11.1.20.3 Recent developments 376
11.1.20.3.1 Product/Service launches 376
11.1.20.3.2 Deals 377
 
11.1.21 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD. 378
11.1.21.1 Business overview 378
11.1.21.2 Products/Services offered 379
11.1.21.3 Recent developments 380
11.1.21.3.1 Product/Service launches 380
11.2 OTHER PLAYERS 381
11.2.1 CARESIMPLE INC. 381
11.2.2 TIMEDOC, INC. 382
11.2.3 MD REVOLUTION INC. 383
11.2.4 OPTIMIZE HEALTH, INC. 384
11.2.5 HEALTH RECOVERY SOLUTIONS 385
12 APPENDIX 386
12.1 DISCUSSION GUIDE 386
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 391
12.3 CUSTOMIZATION OPTIONS 393
12.4 RELATED REPORTS 394
12.5 AUTHOR DETAILS 395